» Articles » PMID: 26227533

First Determination of the Heart-to-mediastinum Ratio Using Cardiac Dual Isotope (¹²³I-MIBG/⁹⁹mTc-tetrofosmin) CZT Imaging in Patients with Heart Failure: the ADRECARD Study

Overview
Date 2015 Aug 1
PMID 26227533
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Cardiac innervation is assessed using the heart-to-mediastinum ratio (HMR) of metaiodobenzylguanidine (MIBG) on planar imaging using Anger single photon emission computed tomography (A-SPECT). The aim of the study was to determine the HMR of MIBG obtained using a CZT-based camera (D-SPECT; Spectrum Dynamics, Israel) in comparison with that obtained using conventional planar imaging.

Methods: The ADRECARD study prospectively evaluated 44 patients with heart failure. They underwent planar acquisition using the A-SPECT camera 4 h after (123)I-MIBG injection (236.4 ± 39.7 MBq). To localize the heart using D-SPECT, (99m)Tc-tetrofosmin (753 ± 133 MBq) was administered and dual isotope acquisition was performed using the D-SPECT system. HMR was calculated using both planar A-SPECT imaging and front view D-SPECT cine data. In a phantom study, we estimated a model fitting the A-SPECT and the D-SPECT data that was further applied to correct for differences between the cameras.

Results: A total of 44 patients (39 men and 5 women, aged 60 ± 11 years) with ischaemic (31 patients) and nonischaemic (13 patients) cardiomyopathy completed the study. Most patients (28 of 44) were NYHA class II, and the mean left ventricular ejection fraction was 33 ± 7 %. The mean HMR values were 1.34 ± 0.15 and 1.45 ± 0.27 from A-SPECT and D-SPECT, respectively (p < 0.0001). After correction, Lin's concordance correlation showed an almost perfect concordance between corrected D-SPECT HMR and A-SPECT HMR, and Bland-Altman analysis demonstrated a high agreement between the two measurements.

Conclusion: The ADRECARD study demonstrated that determination of late HMR during cardiac MIBG imaging using dual isotope ((123)I and (99m)Tc) acquisition on a CZT camera (D-SPECT) is feasible in patients with heart failure. A linear correction based on the phantom study yielded a high agreement between (123)I MIBG HMR obtained using a CZT camera and that from conventional planar imaging.

Citing Articles

.

Sweet C, Shmuel N, Shoaf J, Stoecklein M, Muthukrishnan A, Stern E Nucl Med Mol Imaging. 2024; 58(1):1-8.

PMID: 38250182 PMC: 10796310. DOI: 10.1007/s13139-023-00825-2.


Phantom-Based Standardization Method for I-metaiodobenzylguanidine Heart-to-Mediastinum Ratio Validated by D-SPECT Versus Anger Camera.

Yamashita S, Nakajima K, Okuda K, Yamamoto H, Shibutani T, Yoneyama T Ann Nucl Cardiol. 2023; 9(1):85-90.

PMID: 38058581 PMC: 10696155. DOI: 10.17996/anc.23-00003.


Current and potential roles of immuno-PET/-SPECT in CAR T-cell therapy.

Mulgaonkar A, Udayakumar D, Yang Y, Harris S, Oz O, Ramakrishnan Geethakumari P Front Med (Lausanne). 2023; 10:1199146.

PMID: 37441689 PMC: 10333708. DOI: 10.3389/fmed.2023.1199146.


Are nuclear medicine images quantified in 2D and 3D equally functional?.

Nakajima K, Shibutani T J Nucl Cardiol. 2023; 30(5):1968-1972.

PMID: 37156963 DOI: 10.1007/s12350-023-03290-8.


The value of cardiac sympathetic activity and mechanical dyssynchrony as cardiac resynchronization therapy response predictors: comparison between patients with ischemic and non-ischemic heart failure.

Mishkina A, Saushkin V, Atabekov T, Sazonova S, Shipulin V, Massalha S J Nucl Cardiol. 2022; 30(1):371-382.

PMID: 35834158 DOI: 10.1007/s12350-022-03046-w.


References
1.
Lin L . A concordance correlation coefficient to evaluate reproducibility. Biometrics. 1989; 45(1):255-68. View

2.
Merlet P, Benvenuti C, Moyse D, Pouillart F, Dubois-Rande J, DUVAL A . Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med. 1999; 40(6):917-23. View

3.
Imbert L, Poussier S, Franken P, Songy B, Verger A, Morel O . Compared performance of high-sensitivity cameras dedicated to myocardial perfusion SPECT: a comprehensive analysis of phantom and human images. J Nucl Med. 2012; 53(12):1897-903. DOI: 10.2967/jnumed.112.107417. View

4.
Pellegrino T, Petretta M, De Luca S, Paolillo S, Boemio A, Carotenuto R . Observer reproducibility of results from a low-dose 123I-metaiodobenzylguanidine cardiac imaging protocol in patients with heart failure. Eur J Nucl Med Mol Imaging. 2013; 40(10):1549-57. DOI: 10.1007/s00259-013-2461-4. View

5.
Nakajima K, Okuda K, Yoshimura M, Matsuo S, Wakabayashi H, Imanishi Y . Multicenter cross-calibration of I-123 metaiodobenzylguanidine heart-to-mediastinum ratios to overcome camera-collimator variations. J Nucl Cardiol. 2014; 21(5):970-8. PMC: 4167440. DOI: 10.1007/s12350-014-9916-2. View